Type 2 diabetes (T2D) has reached epidemic proportions in the US. Nutrition therapy (NT) plays a critical role in T2D management. Osama Hamdy, MD, PhD of the Joslin Diabetes Center at Harvard Medical School is the principal investigator of a randomized trial recently published in Nutrition Journal , which examined 3 NT approaches head-to-head to determine the optimal NT model for improving HbA1c and cardiovascular disease risk factors in overweight and obese patients with T2D.